Concepedia

Steven Kao

SK

Statistics

Publications

21

Citations

1.5K

H-Index

16

Active since

2009

Affiliations

Chris O’Brien Lifehouse(Current)

The University of Sydney

Royal Prince Alfred Hospital

Asbestos Diseases Research Institute

Royal North Shore Hospital

Steven Kao is an author at Chris O’Brien Lifehouse specializing in oncology, medicine, and malignant neoplasms.

Publications per year

2009–2025

21

Publications

21

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

Nico van Zandwijk, Nick Pavlakis, Steven Kao et al. · The Lancet Oncology · 2017 · 709 citations

Medicine, Oncology, Pharmacology +15

Use of chemotherapy at end of life in oncology patients

Steven Kao, Jesmin Shafiq, Janette L. Vardy et al. · Annals of Oncology · 2009 · 157 citations

Medicine, Oncology, Chemotherapy +11

Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy

Steven Kao, Sonja Klebe, Douglas W. Henderson et al. · Journal of Thoracic Oncology · 2011 · 91 citations · Full text

Medicine, Oncology, Pathology +16

Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study

Aurélien Marabelle, Philippe A. Cassier, Marwan Fakih et al. · The Lancet. Gastroenterology & hepatology · 2022 · 73 citations · Full text

Medicine, Oncology, Pharmacology +7

Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy

David Levy, Haryana M. Dhillon, Anna J. Lomax et al. · Supportive Care in Cancer · 2018 · 68 citations

Medicine, Clinical Sciences, Oncology +15

1–5 of 21